Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control (CGM)
Metabolic Disease, Adipose Tissue
About this trial
This is an interventional basic science trial for Metabolic Disease focused on measuring Exercise
Eligibility Criteria
Inclusion criteria
- Age: 18-40
- Body Mass Index: 20-30 kg/m2
Exclusion criteria
- Pregnant or lactating
- Evidence/history of cardiovascular or metabolic disease
- Medications known to affect glucose metabolism
Sites / Locations
- University of Michigan
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Trial 1
Trial 2
Subjects will have two CGM devices placed on either side of the abdomen, near the belly button. Trial 1 Exercise - subjects will use a mouthpiece and nose clip (which will allow all of their expired air to pass through the metabolic cart for analysis of oxygen consumption and carbon dioxide production) for ~5 min at the beginning, middle and toward the end of exercise to verify they are exercising at 65% of VO2peak. This will allow us to accurately measure energy expenditure (kcal) during exercise. One hour after the exercise session, participants will eat a standardized dinner which includes the energy expended from their exercise session (+ 350 kcal).
Subjects will have one CGM device placed on one side of the abdomen. Trial 2 Exercise - subjects will exercise at 65% of VO2peak. One hour after the exercise session, participants will eat a standardized dinner which will NOT include the energy expended from their exercise session (- 350 kcal).